Esomeprazole Magnesium

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

132 Suppliers, 63 USDMF, 48 CEP/COS, 6 JDMF, 39 EU WC, 79 KDMF, 45 NDC API, 63 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

15 Suppliers

15 Suppliers

DOSSIERs // Finished Dosage Forms

767 Dossiers, 90 FDA Orange Book, 359 Europe, 23 Canada, 86 Australia, 52 South Africa, 157 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE, DELAYED RELEASE;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 40MG BASE, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET, FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 30 BASF, 19 Kerry, 18 Roquette, 17 SPI Pharma, 15 Corel Pharma Chem, 14 Seppic, 13 Ideal Cures Pvt Ltd, 11 Microlex e.U, 11 Gangwal Chemicals, 10 Sigachi Industries, 10 Gangwal Healthcare, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 Actylis, 6 Lonza Capsugel, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 Prachin Chemical, 4 ACG Worldwide, 4 Ingredion Pharma Solutions, 4 Nanjing Well Pharmaceutical, 4 Kima Chemical, 3 The Dow Chemical Company, 3 Vasa Pharmachem, 3 Jai Radhe Sales, 3 Doshion Polyscience, 3 Pharmatrans-Sanaq, 3 DKSH, 3 Boai NKY Pharmaceuticals Ltd, 3 DFE Pharma, 2 Qualicaps, 2 Evonik, 2 Alcedo Pharmachem, 2 Pfanstiehl, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Ulanqab Kema New Material, 2 Seqens, 2 Finar, 1 Aeon Procare, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 NEWEDGE Overseas, 1 Chynops Pharma, 1 Rochem International Inc, 1 Minakem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

68 Coating Systems & Additives, 64 Fillers, Diluents & Binders, 43 Controlled & Modified Release, 34 Direct Compression, 29 Solubilizers, 26 Taste Masking, 26 Thickeners and Stabilizers, 24 Disintegrants & Superdisintegrants, 24 Granulation, 20 Lubricants & Glidants, 17 Chewable & Orodispersible Aids, 16 Film Formers & Plasticizers, 16 Co-Processed Excipients, 15 Topical, 14 Parenteral, 9 Empty Capsules, 6 API Stability Enhancers, 6 Emulsifying Agents, 4 Vegetarian Capsules, 4 Rheology Modifiers, 3 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

23 US Medicaid Prescriptions, 290 Finished Drug Prices

MARKET PLACE

64 APIs, 35 DOSSIERS // FDF

PATENTS

2 US Patents, 44 Health Canada Patents

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 5 EDQM Standards, 1 USP Standards, 21 Other Ref. Standards

DIGITAL CONTENT

15 Data Compilation & Company Tracker #PharmaFlow, 149 News

Information, Expiry & Status of Health Canada Patents covering Esomeprazole Magnesium.

Esomeprazole Magnesium

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

132 Suppliers

63 USDMF

48 CEP/COS

6 JDMF

39 EU WC

79 KDMF

45 NDC API

63 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

15 Suppliers

DOSSIERs // Finished Dosage Forms

767 Dossiers

90 FDA Orange Book

359 Europe

23 Canada

86 Australia

52 South Africa

157 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE, DELAYED RELEASE;ORAL - EQ 20MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 40MG BASE

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 2.5MG BASE/PACKET

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 20MG BASE/PACKET

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 40MG BASE/PACKET

FOR SUSPENSION, DELAYED RELEASE;ORAL - EQ 5MG BASE/PACKET

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

30 BASF

19 Kerry

18 Roquette

17 SPI Pharma

15 Corel Pharma Chem

14 Seppic

13 Ideal Cures Pvt Ltd

11 Microlex e.U

11 Gangwal Chemicals

10 Sigachi Industries

10 Gangwal Healthcare

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 Actylis

6 Lonza Capsugel

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Prachin Chemical

4 ACG Worldwide

4 Ingredion Pharma Solutions

4 Nanjing Well Pharmaceutical

4 Kima Chemical

3 The Dow Chemical Company

3 Vasa Pharmachem

3 Jai Radhe Sales

3 Doshion Polyscience

3 Pharmatrans-Sanaq

3 DKSH

3 Boai NKY Pharmaceuticals Ltd

3 DFE Pharma

2 Qualicaps

2 Evonik

2 Alcedo Pharmachem

2 Pfanstiehl

2 Nanjing Bold Chemical

2 Nomisma Healthcare

2 Ulanqab Kema New Material

2 Seqens

2 Finar

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;375MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, DELAYED RELEASE;ORAL - EQ 20MG BASE;500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons